Association between cardio-ankle vascular index and cardiometabolic risk factors in HIV patients in Ghana

References

• Joint United Nations Programme on HIV/AIDS. Global HIV & AIDS statistics — Fact sheet. Geneva, Switzerland: UNAIDS; 2021 [cited 2023 January 10]. Available from: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
   Google Scholar
• Defo AK, Chalati MD, Labos C, et al. Association of HIV infection and antiretroviral therapy with arterial stiffness: a systematic review and meta-analysis. Hypertension. 2021;78(2):320–9.
   PubMed Web of Science ®Google Scholar
• Bijker R, Jiamsakul A, Uy E, et al. Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2019;20(3):183–191. DOI:10.1111/hiv.12687
   PubMed Web of Science ®Google Scholar
• Fourie CMT, Schutte AE, Smith W, et al. Endothelial activation and cardiometabolic profiles of treated and never-treated HIV infected Africans. Atherosclerosis. 2015;240(1):154–160.
   PubMed Web of Science ®Google Scholar
• Kim ED, Ballew SH, Tanaka H, et al. Short-term prognostic impact of arterial stiffness in older adults without prevalent cardiovascular disease. Hypertension. 2019;74(6):1373–1382.
   PubMed Web of Science ®Google Scholar
• Shirai K, Utino J, Otsuka K, et al. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13(2):101–107.
   PubMed Web of Science ®Google Scholar
• Shirai K, Suzuki K, Tsuda S, et al. Comparison of cardio–ankle vascular index (CAVI) and CAVI0 in large healthy and hypertensive populations. J Atheroscler Thromb. 2019;26(7):603–615.
   PubMed Web of Science ®Google Scholar
• Aiumtrakul N, Supasyndh O, Krittayaphong R, et al. Cardio-ankle vascular index with renal progression and mortality in high atherosclerosis risk: a prospective cohort study in CORE-Thailand. Clin Exp Nephrol. 2022;26(3):247–256.
   PubMed Web of Science ®Google Scholar
• Satoh-Asahara N, Kotani K, Yamakage H, et al. Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: a multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: jOMS). Atherosclerosis. 2015;242(2):461–468.
   PubMed Web of Science ®Google Scholar
• Murakami K, Inayama E, Itoh Y, et al. The role of cardio-ankle vascular index as a predictor of mortality in patients on maintenance hemodialysis. Vasc Health Risk Manag. 2021;17:791–798.
   PubMed Web of Science ®Google Scholar
• Botha S, Fourie CMT, van Rooyen JM, et al. Cardiometabolic changes in treated versus never treated HIV-Infected black South Africans: the PURE study. Heart Lung & Circulation. 2014;23(2):119–126.
   PubMed Web of Science ®Google Scholar
• Gleason RL Jr., Caulk AW, Seifu D, et al. Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) use correlates with elevate markers of atherosclerosis in HIV-Infected subjects in Addis Ababa, Ethiopia. PLoS ONE. 2015;10(4):e0117125.
   PubMed Web of Science ®Google Scholar
• Huisman HW, Schutte R, Venter HL, et al. Low BMI is inversely associated with arterial stiffness in Africans. British Journal Of Nutrition. 2015;113(10):1621–1627.
   PubMed Web of Science ®Google Scholar
• Lemogoum D, Ngatchou W, Borne PVD, et al. Cardiometabolic phenotype and arterial stiffness in HIV-Positive black African Patients. Open J Prev Med. 2014;04(04):11. DOI:10.4236/ojpm.2014.44024
   Google Scholar
• Aurpibul L, Srithanaviboonchai K, Rerkasem K, et al. Prevalence of subclinical atherosclerosis and risk of atherosclerotic cardiovascular disease in older adults living with HIV. AIDS Res Human Retroviruses. 2019;35(11–12):1136–1142.
   PubMed Web of Science ®Google Scholar
• Jewpakanon T, Satitthummanid S, Songmuang SB. Subclinical left ventricular dysfunction virologically supressed HIV-infected patients receiving antiretroviral therapy. J Am Coll Cardiol. 2022;79(9_Supplement):1348.
   Web of Science ®Google Scholar
• Schutte AE, Kruger R, Gafane-Matemane LF, et al. Ethnicity and arterial stiffness. Arteriosclerosis Thrombosis Vasc Biol. 2020;40(5):1044–1054.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–1645.
   PubMed Web of Science ®Google Scholar
• Sun C-K. Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness. Integr Blood Press Control. 2013;6:27.
   PubMedGoogle Scholar
• Shirai K, Utino J, Saiki A, et al. Evaluation of blood pressure control using a new arterial stiffness parameter, Cardio-ankle Vascular Index (CAVI). Curr Hypertens Rev. 2013;9(1):66–75.
   PubMedGoogle Scholar
• Yeboah K, Musah L, Essel S, et al. P98 impaired pulmonary function is associated with increased cardio-ankle vascular index in HIV patients in Ghana. Artery Research. 2020;25(Supplement 1):S139.
   Google Scholar
• Msoka TF, Van Guilder GP, Smulders YM, et al. Antiretroviral treatment and time since HIV-1 diagnosis are associated with large artery stiffness in sub-Saharan African HIV-1 patients. Artery Research. 2016;16:34–41.
   Web of Science ®Google Scholar
• Ngatchou W, Lemogoum D, Ndobo P, et al. Effects of antiretroviral therapy on arterial stiffness in Cameroonian HIV-infected patients. Blood Press Monit. 2013;18(5):247–251. DOI:10.1097/MBP.0b013e328363ee43
   PubMed Web of Science ®Google Scholar
• Yeboah K, Antwi DA, Gyan B, et al. Arterial stiffness in hypertensive and type 2 diabetes patients in Ghana: comparison of the cardio-ankle vascular index and central aortic techniques. BMC Endocr Disord. 2016;16(1):53.
   PubMedGoogle Scholar
• Atkinson J. Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences. J Appl Physiol. 2008;105(5):1643–1651.
   PubMed Web of Science ®Google Scholar
• Lee H-Y, Oh B-H. Aging and arterial stiffness. Circ J. 2010;74(11):2257–2262.
   PubMed Web of Science ®Google Scholar
• Soska V, Dobsak P, Dusek L, et al. Cardio-ankle vascular index in heterozygous familial hypercholesterolemia. J Atheroscler Thromb. 2012;19(5):453–461.
   PubMed Web of Science ®Google Scholar
• Yeboah K, Antwi DA, Gyan B. Arterial stiffness in nonhypertensive type 2 diabetes patients in Ghana. Int J Endocrinol. 2016;2016:6107572.
   PubMed Web of Science ®Google Scholar
• Schillaci G, Socio GVLD, Pucci G, et al.: Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension 2008, 52(2):308–313.
   PubMed Web of Science ®Google Scholar
• Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso MC, et al. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial. Cardiovasc Diabetol. 2016;15(1):148.
   PubMedGoogle Scholar
• Kumar S, Samaras K. The impact of weight gain during HIV treatment on risk of pre-diabetes, diabetes mellitus, cardiovascular disease, and mortality. Front Endocrinol (Lausanne). 2018;9:9.
   PubMed Web of Science ®Google Scholar
• Tate T, Willig AL, Willig JH, et al. HIV infection and obesity: where did all the wasting go? Antivir Ther. 2012;17(7):1281–1289.
   PubMed Web of Science ®Google Scholar
• Zhao D, Ding Y, Lin H, et al. Mitochondrial Haplogroups N9 and G are associated with metabolic syndrome among human immunodeficiency virus-infected patients in China. AIDS Res Human Retroviruses. 2019;35(6):536–543.
   PubMed Web of Science ®Google Scholar
• Sitole L, Fortuin R, Tugizimana F. Metabolic profiling of HIV infected individuals on an AZT-based antiretroviral treatment regimen reveals persistent oxidative stress. J Pharm Biomed Anal. 2022;220:114986.
   PubMed Web of Science ®Google Scholar
• Alzate Angel JC, Duque Molina MM, García García HI. Zidovudine/Lamivudine vs. Abacavir/Lamivudine vs. Tenofovir/Emtricitabine in fixed-dose combinations as initial treatment for HIV patients: a systematic review and network meta-analysis. Colombia Médica. 2017;48(2):70–81.
   PubMed Web of Science ®Google Scholar
• Dadi TL, Kefale AT, Mega TA, et al. Efficacy and tolerability of tenofovir disoproxil fumarate based regimen as compared to zidovudine based regimens: a systematic review and meta-analysis. AIDS Res Treat. 2017;2017:5792925.
   PubMedGoogle Scholar